Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163186 · ClinicalTrials.gov registry record
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 55
- Enrollment target
NCT03163186 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 55 participants.
The verdict
NCT03163186 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
To evaluate the safety, advantages, and appropriateness of performing transarterial hepatic emobolization of liver cancer via arterial access from the radial artery versus conventional transfemoral arterial access. The procedures that will be followed utilizing arterial access include transarterial chemoembolization (TACE), specifically performed for hepatocellular carcinoma, and transarterial embolization (TAE) which is performed for types of liver tumors such as carcinoid tumors or liver metastases.
Interventions
- PROCEDURE Transarterial embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-12-01 |
| Est. Completion | 2016-08-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03163186
The ClinicalTrials.gov registry entry for NCT03163186 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transarterial embolization is the first listed.
NCT03163186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03163186 about?
NCT03163186 is a clinical study titled "Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).". To evaluate the safety, advantages, and appropriateness of performing transarterial hepatic emobolization of liver cancer via arterial access from the radial artery versus conventional transfemoral arterial access. The procedures that will be followed utilizing arterial access include transarterial ...
What is the current status of trial NCT03163186?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2015-12-01. Estimated completion is 2016-08-18.
What interventions are being tested in trial NCT03163186?
The interventions under investigation include: Transarterial embolization (PROCEDURE).
Who is sponsoring clinical trial NCT03163186?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.